Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling

Fig. 3

LC3 accumulates in autophagosomes in cells treated with Obatoclax. a Immunofluorescence staining for LC3 in untreated (upper panel), Chloroquine treated (30 μM, middle panel) and obatoclax treated (0.25 μM, lower panel) cells. Representative pictures are shown. Assays were done at least three times. b Analysis of LC3 aggregates per cell. Values are expressed as mean ± SD. *** = p < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us